Literature DB >> 23183786

The role of phosphatases in the initiation of skeletal mineralization.

José Luis Millán1.   

Abstract

Endochondral ossification is a carefully orchestrated process mediated by promoters and inhibitors of mineralization. Phosphatases are implicated, but their identities and functions remain unclear. Mutations in the tissue-nonspecific alkaline phosphatase (TNAP) gene cause hypophosphatasia, a heritable form of rickets and osteomalacia, caused by an arrest in the propagation of hydroxyapatite (HA) crystals onto the collagenous extracellular matrix due to accumulation of extracellular inorganic pyrophosphate (PPi), a physiological TNAP substrate and a potent calcification inhibitor. However, TNAP knockout (Alpl(-/-)) mice are born with a mineralized skeleton and have HA crystals in their chondrocyte- and osteoblast-derived matrix vesicles (MVs). We have shown that PHOSPHO1, a soluble phosphatase with specificity for two molecules present in MVs, phosphoethanolamine and phosphocholine, is responsible for initiating HA crystal formation inside MVs and that PHOSPHO1 and TNAP have nonredundant functional roles during endochondral ossification. Double ablation of PHOSPHO1 and TNAP function leads to the complete absence of skeletal mineralization and perinatal lethality, despite normal systemic phosphate and calcium levels. This strongly suggests that the Pi needed for initiation of MV-mediated mineralization is produced locally in the perivesicular space. As both TNAP and nucleoside pyrophosphohydrolase-1 (NPP1) behave as potent ATPases and pyrophosphatases in the MV compartment, our current model of the mechanisms of skeletal mineralization implicate intravesicular PHOSPHO1 function and Pi influx into MVs in the initiation of mineralization and the functions of TNAP and NPP1 in the extravesicular progression of mineralization.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23183786      PMCID: PMC3594124          DOI: 10.1007/s00223-012-9672-8

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  56 in total

1.  Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone.

Authors:  Monzur Murshed; Dympna Harmey; José Luis Millán; Marc D McKee; Gerard Karsenty
Journal:  Genes Dev       Date:  2005-04-15       Impact factor: 11.361

2.  The Possible Significance of Hexosephosphoric Esters in Ossification.

Authors:  R Robison
Journal:  Biochem J       Date:  1923       Impact factor: 3.857

3.  Probing the substrate specificities of human PHOSPHO1 and PHOSPHO2.

Authors:  Scott J Roberts; Alan J Stewart; Ralf Schmid; Claudia A Blindauer; Stephanie R Bond; Peter J Sadler; Colin Farquharson
Journal:  Biochim Biophys Acta       Date:  2005-08-31

4.  Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization.

Authors:  Yuji Yoshiko; G Antonio Candeliere; Norihiko Maeda; Jane E Aubin
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

5.  Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick.

Authors:  Vicky E Macrae; Megan G Davey; Lynn McTeir; Sonoko Narisawa; Manisha C Yadav; Jose Luis Millan; Colin Farquharson
Journal:  Bone       Date:  2010-01-04       Impact factor: 4.398

6.  PHOSPHO1-A novel phosphatase specifically expressed at sites of mineralisation in bone and cartilage.

Authors:  Brian Houston; Alan J Stewart; Colin Farquharson
Journal:  Bone       Date:  2004-04       Impact factor: 4.398

7.  Inorganic pyrophosphatase induces type I collagen in osteoblasts.

Authors:  Monika D Polewski; Kristen A Johnson; Melissa Foster; José Luis Millán; Robert Terkeltaub
Journal:  Bone       Date:  2009-09-03       Impact factor: 4.398

8.  Enzyme replacement therapy for murine hypophosphatasia.

Authors:  José Luis Millán; Sonoko Narisawa; Isabelle Lemire; Thomas P Loisel; Guy Boileau; Pierre Leonard; Svetlana Gramatikova; Robert Terkeltaub; Nancy Pleshko Camacho; Marc D McKee; Philippe Crine; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

9.  Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization.

Authors:  Scott Roberts; Sonoko Narisawa; Dympna Harmey; José Luis Millán; Colin Farquharson
Journal:  J Bone Miner Res       Date:  2007-04       Impact factor: 6.741

10.  Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: a unified model of the mechanisms of initiation of skeletal calcification.

Authors:  Manisha C Yadav; Ana Maria Sper Simão; Sonoko Narisawa; Carmen Huesa; Marc D McKee; Colin Farquharson; José Luis Millán
Journal:  J Bone Miner Res       Date:  2010-08-03       Impact factor: 6.741

View more
  104 in total

Review 1.  Clinical management of hypophosphatasia.

Authors:  Nick Bishop
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26

Review 2.  The rachitic tooth.

Authors:  Brian L Foster; Francisco H Nociti; Martha J Somerman
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

3.  Estrogen and phenol red free medium for osteoblast culture: study of the mineralization ability.

Authors:  A N de Faria; D C Zancanela; A P Ramos; M R Torqueti; P Ciancaglini
Journal:  Cytotechnology       Date:  2015-01-30       Impact factor: 2.058

Review 4.  Expression and function of Slc34 sodium-phosphate co-transporters in skeleton and teeth.

Authors:  Laurent Beck
Journal:  Pflugers Arch       Date:  2018-12-03       Impact factor: 3.657

5.  Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia.

Authors:  S A Bowden; B H Adler
Journal:  Osteoporos Int       Date:  2018-07-02       Impact factor: 4.507

Review 6.  Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.

Authors:  Mathias Haarhaus; Vincent Brandenburg; Kamyar Kalantar-Zadeh; Peter Stenvinkel; Per Magnusson
Journal:  Nat Rev Nephrol       Date:  2017-05-15       Impact factor: 28.314

7.  Dual role of the Trps1 transcription factor in dentin mineralization.

Authors:  Maria Kuzynski; Morgan Goss; Massimo Bottini; Manisha C Yadav; Callie Mobley; Tony Winters; Anne Poliard; Odile Kellermann; Brendan Lee; Jose Luis Millan; Dobrawa Napierala
Journal:  J Biol Chem       Date:  2014-08-15       Impact factor: 5.157

8.  Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis.

Authors:  M Ao; M B Chavez; E Y Chu; K C Hemstreet; Y Yin; M C Yadav; J L Millán; L W Fisher; H A Goldberg; M J Somerman; B L Foster
Journal:  Bone       Date:  2017-09-01       Impact factor: 4.398

9.  Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality.

Authors:  Yu Shao; Emily Wichern; Paul J Childress; Michele Adaway; Jagannath Misra; Angela Klunk; David B Burr; Ronald C Wek; Amber L Mosley; Yunlong Liu; Alexander G Robling; Nickolay Brustovetsky; James Hamilton; Kylie Jacobs; Deepak Vashishth; Keith R Stayrook; Matthew R Allen; Joseph M Wallace; Joseph P Bidwell
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-01-15       Impact factor: 4.310

10.  Insights into dental mineralization from three heritable mineralization disorders.

Authors:  Michael B Chavez; Kaitrin Kramer; Emily Y Chu; Vivek Thumbigere-Math; Brian L Foster
Journal:  J Struct Biol       Date:  2020-08-03       Impact factor: 2.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.